Inositec AG
Industry
- Biotechnology
- Drug Discovery Technologies
- Molecular Diversity
- Natural Products
- Molecular Diversity
- Drug Discovery Technologies
- Pharmaceuticals
See more in Biomedtracker
Latest on Inositec AG
Scrip
• By Alex Shimmings
The Australian biotech leader CSL Limited is to buy Vifor Pharma Group to beef up its renal presence and move into some adjacent therapeutic areas which, it believes, have high growth potential.
Scrip
• By Kevin Grogan
Vifor Pharma Group has hit the M&A trail again to bolster its nephrology pipeline by acquiring promising Spanish biotech Sanifit Therapeutics S.A. and fellow Swiss group Inositec AG with the hop
Scrip
• By Lucie Ellis-Taitt
Inositec AG is developing innovative new drugs using its proprietary Inositune technology to adjust the properties of inositol phosphate analogs. Initially, the company will focus on two areas of hi